Home
Advisory Panel
Conferences & Events
SEARCH:
GO
Symptom Management
Hypertension and Targeted Therapies for Cancer
Chemotherapy-Induced Nausea and Vomiting Updated
Hand-Foot Skin Reaction
Cutaneous Toxicities With Targeted Therapy
Hand-Foot Syndrome (HFS) Updated
Ocular Changes Secondary to Chemotherapy
Anorexia-Cachexia Syndrome
HSRs:Uniphasic,Biphasic,Delayed
National Cancer Institute Updates CTCAE to v.4.03
[
View more Symptom Management articles
]
Clinical Trials Search
Continuing Education
[
View more Continuing Education articles
]
MCRC News
Long-Term Effects of Aspirin on Cancer Risk & CRC
Cancer Fatalism and Poor Self-Rated Health
Sex-Specific Prevalence of Adenomas and CRC
Mortality by Stage: Right Vs. Left Colon Cancer
Assessment of Family History of Colorectal Cancer
Updates in Symptom Management - CINV and OIPN
Dr. William Wolff and the Colonoscopy
Vitamin D Deficiency or Diabetes: CRC Risk?
Polish Patients With Advanced Colorectal Cancer
[
View more News Articles
]
CRC: Clinical Updates
Staging of Colorectal Cancer (CRC)
Biologically Based CAM in Cancer Care
Vitamin D Status and Risk of CRC: A Review
Genomics in CRC 2/2: Hereditary CRC Syndromes
Genomics in CRC 1/2
Treatment Considerations in the Elderly
Cancer Survivorship
Drug Interactions
Local Ablation of Liver Metastases
Colonic Polyps: Pathology
[
View more Clinical Updates
]
Tools & Resources
Video Library
Symptom Management: Hypertension and Targeted Therapies for Cancer
|
News: Sex-Specific Prevalence of Adenomas, Advanced Adenomas, and CRC in Individuals Undergoing Screening Colonoscopy
|
News: Long-Term Effect of Aspirin on Cancer Risk in Carriers of Hereditary Colorectal Cancer
|
News: Cancer Fatalism and Poor Self-Rated Health in England
|
News: Mortality by Stage for Right- Versus Left-Sided Colon Cancer
|
Clinical Updates: Staging of Colorectal Cancer (CRC)
|
News: Assessment of Family History of Colorectal Cancer
|
Clinical Updates: Colorectal Cancer Screening
|
News: Updates in Symptom Management: Chemotherapy-Induced Nausea and Vomiting, and Oxaliplatin-Induced Peripheral Neuropathy
|
News: Dr. William Wolff and the Colonoscopy: Making a Difference that Saves Lives
|
News: Vitamin D Deficiency or Diabetes: Independent Risk Factors for Colorectal Cancer?
|
News: Polish Patients With Advanced Colorectal Cancer Undergoing First-Line Palliative Chemotherapy
|
News: Concordance of Predictive Markers for EGFR Inhibitors
|
News: One-time Sigmoidoscopy in Screening for CRC
|
News: Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
|
News: MRI-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes
|
News: Gastrointestinal Cancer and Brain Metastases
|
News: Development and Psychometric Evaluation of a CIPN Assessment Tool
|
News: Longitudinal Analysis of Patient-Physician Communication
|
News: Supporting Treatment Decision Making in Advanced Cancer
|
News: Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer
|
News: Cancer Statistics 2011
|
Symptom Management: Chemotherapy-Induced Nausea and Vomiting Updated
|
Symptom Management: Hand-Foot Skin Reaction
|
Symptom Management: Cutaneous Toxicities Associated With Targeted Therapy
|
News: Tumor Status at 12 Weeks Predicts Survival in Advanced Colorectal Cancer: Findings from NCCTG N9741
|
Symptom Management: Hand-Foot Syndrome (HFS) Updated
|
News: 12-Gene Colon Cancer Recurrence Score Identifies Stage II Colon Cancer With Higher Risk of Recurrence
|
News: Lynch Syndrome: Identifying Patients at Risk for HNPCC
|
News: Meta-Analysis Outcomes of Anastomotic Leak
|
Symptom Management: Ocular Changes Secondary to Chemotherapy
|
News: Perioperative Assessment and Intervention May Improve Long-term Outcomes after CRC Resection in Older Adults
|
News: Type D Personality and QOL in CRC Survivors
|
News: Seminar in Oncology Nursing on Oral Adherence
|
News: Personalized Medicine Webinar
|
News: Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
|
News: Peripheral Neuropathy in Patients with Colorectal Cancer Receiving Oxaliplatin
|
News: XELOX as Adjuvant Therapy for Stage III Colon Cancer
|
News: AVACROSS Study: Locally Advanced Rectal Cancer
|
News: Colorectal Cancer Epigenetics
|
News:Value of Mismatch Repair, KRAS & BRAF Mutations in Predicting Recurrence and Benefits from Chemotherapy in Coloretal Cancer
|
News: Vitamin D Status in Patients with Stage IV Colorectal Cancer: Findings from Intergroup Trial N9741
|
News: Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401
|
News: Celebrate National Cancer Survivors Day
|
News: NCI Releases FY 2009 CAM Report
|
News: Fight Colorectal Cancer
|
News: Alcohol Drinking and Colorectal Cancer Risk Meta-analysis
|
News: High Survival Rates after Two-stage Resection of CRC Liver Metastases
|
News: Interventions for Preventing Neuropathy Caused by Cisplatin and Related Compounds
|
News: Short Duration of Sleep Increases Risk of Colorectal Adenoma
|
News: ASCO Advanced Cancer Care Planning Booklet
|
News: Histopathologic-based Prognostic Factors of CRC
|
News: Bevacizumab-related Mortality in Patients with Cancer
|
News: FDA Limits Acetaminophen in Prescription Drug Products
|
News: Use of Bisphosphonates and Reduced Risk of Colorectal Cancer (CRC)
|
News: Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy
|
News: National Safe Handling Awareness Month Returns in April 2011
|
News: Specialty Physician Recruitment to Cancer Clinical Trials
|
Sex-Specific Prevalence of Adenomas and CRC
Long-Term Effects of Aspirin on Cancer Risk and CRC
...
Cancer Fatalism and Poor Self-Rated Health
...
Mortality by Stage: Right- Vs. Left-Sided Colon Cancer
...
Hypertension and Targeted Therapies for Cancer
...
Chemotherapy-Induced Nausea and Vomiting Updated
...
Hand-Foot Skin Reaction
...
Cutaneous Toxicities Associated With Targeted Therapy
...
Does Sunscreen Prevent EGFR Inhibitor-Induced Rash?
FDA Panel Supports Use of Gardasil® for Anal Cancer
...
Prophylactic Tetracycline Does Not Diminish EGFRI Rash
...
The PRIME Study: Panitumumab-FOLFOX4 vs FOLFOX alone
...
Disclaimer
Privacy
Contact